FindTrial
Sign In

A multicenter, prospective, randomized controlled trial of Chinese children with hepatoblastoma

A multicenter, prospective, randomized controlled trial of Chinese children with hepatoblastoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017935
Enrollment
Unknown
Registered
2018-08-22
Start date
2018-08-22
Completion date
Unknown
Last updated
2018-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatoblastoma

Interventions

Case series:None

Sponsors

Xinhua Hospital Affiliated to Shanghai Jiaotong University, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 12 Years

Inclusion criteria

Inclusion criteria: 1) Comply with the CCCG-HB-2016 enrollment conditions and strictly follow the HB-2016 regimen; 2) Comply with the hepatoblastoma diagnosis and risk grouping criteria, but according to other treatments. The data ratio of the 2 groups is 2:1.

Exclusion criteria

Exclusion criteria: 1. Patients with unclear pathological or pathological diagnosis; 2. Patients with other malignant tumors; 3. Lack of clear clinical data such as biochemical examination, imaging examination, and physical examination; 4. Incomplete follow-up data; 5. Patients who died within 30 days after surgery.

Design outcomes

Primary

MeasureTime frame
survival time after operation ;—

Countries

China

Contacts

Public ContactYeming Wu & Xiaojun Yuan

Xinhua Hospital Affiliated to Shanghai Jiaotong University, School of Medicine

wuyeming@xinhuamed.com.cn+86 13003178888

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026